# Octreotide long-acting release in the treatment of autosomal dominant polycystic kidney disease: a meta-analysis.

> PubMed lists PMID 41647114 in Frontiers in endocrinology as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2026-01-21 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41647114-octreotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-13
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41647114-octreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41647114-octreotide-v1.json
- Content SHA-256: `875a6a4024dd66eadc9deac7f4558eb1d1e918e0ea06c82370413e66d4b53a24`

## Claims and source pins

### Headline

Octreotide long-acting release in the treatment of autosomal dominant polycystic kidney disease: a meta-analysis. ([`pubmed-observation-pmid-41647114-2026-07-13-bf553f1ffa0c`](#source-pubmed-observation-pmid-41647114-2026-07-13-bf553f1ffa0c))

### Summary

PubMed lists PMID 41647114 in Frontiers in endocrinology as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2026-01-21 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41647114-2026-07-13-bf553f1ffa0c`](#source-pubmed-observation-pmid-41647114-2026-07-13-bf553f1ffa0c))

### Paragraph 1

PubMed lists PMID 41647114 in Frontiers in endocrinology as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2026-01-21 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41647114-2026-07-13-bf553f1ffa0c`](#source-pubmed-observation-pmid-41647114-2026-07-13-bf553f1ffa0c))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41647114-2026-07-13-bf553f1ffa0c`](#source-pubmed-observation-pmid-41647114-2026-07-13-bf553f1ffa0c))

## Sources

<a id="source-pubmed-observation-pmid-41647114-2026-07-13-bf553f1ffa0c"></a>
- **Octreotide long-acting release in the treatment of autosomal dominant polycystic kidney disease: a meta-analysis. · retained source version 1:2026-07-13:current:bf553f1ffa0c8c84c4129b5d97ae42898b5397326628612409b90aa142616489** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41647114/) (`pubmed-observation-pmid-41647114-2026-07-13-bf553f1ffa0c`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Octreotide long-acting release in the treatment of autosomal dominant polycystic kidney disease: a meta-analysis." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41647114-octreotide-v1.json SHA-256: 875a6a4024dd66eadc9deac7f4558eb1d1e918e0ea06c82370413e66d4b53a24.